Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells.

about

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.Anticancer drug discovery from Chinese medicinal herbs.

P2860

Q52716432-94146441-025A-4A77-8070-18E090039417 Q55533017-2494B8F1-BA8C-4742-B926-ECA3FE750B64

P2860

Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells.

Item

http://www.wikidata.org/entity/Q42362435

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@en

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@nl

type

Item

label

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@en

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@nl

prefLabel

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@en

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@nl

P1476

Platycodin D potentiates proli ...... -small cell lung cancer cells.

@en

P2093

Chung Hang Leung

http://www.w3.org/2001/XMLSchema#string

Dik Lung Ma

http://www.w3.org/2001/XMLSchema#string

Ting Li

http://www.w3.org/2001/XMLSchema#string

Xin Chen

http://www.w3.org/2001/XMLSchema#string

Xiuping Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

AKT/PKB signaling: navigating downstream

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Editors' Reply

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

P2888

srep37997

P304

37997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP37997

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jinjian Lu

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27897231

http://www.w3.org/2001/XMLSchema#string

P932

5126555

http://www.w3.org/2001/XMLSchema#string

Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells.

about

P2860

P2860

Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932